| 摘要 |
<p>Biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) event within 5 years are disclosed. The biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. The methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value, the biomarker being selected from a group of biomarkers.</p> |
